General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|13|6|385-394

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.13, Iss.6, 2013-12, pp. : 385-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Biosafety of Viral Vectors Commonly Used in Gene Therapy and Vaccination)

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 383-384

Bentham Science Publishers

Access to resources Recommend Favorite

Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 1

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 478-491

Bentham Science Publishers

Access to resources Recommend Favorite

Use of DNA Microarrays to Monitor Host Response to Virus and Virus-Derived Gene Therapy Vectors

By Stefania Piersanti   Yuri Martina   Gioia Cherubini   Daniele Avitabile   Isabella Saggio  

American Journal of PharmacoGenomics, Vol. 4, Iss. 6, 2004-01 ,pp. : 345-356

Adis International

Access to resources Recommend Favorite

Biosafety Considerations Using Gamma-Retroviral Vectors in Gene Therapy

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 469-477

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Biosafety of Virus-Derived Vectors (Guest Editor: William Moens)]

By  

Current Gene Therapy, Vol. 3, Iss. 6, 2003-12 ,pp. : ii-ii

Bentham Science Publishers

Access to resources Recommend Favorite